Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Photodynamic Therapy Global Market Report 2023. (Just out)

<< Previous

Bullboard Posts

Next >>

Comment by ggrelletteon Mar 31, 2023 11:03am

111 Views

Post# 35371762

RE:RE:Photodynamic Therapy Global Market Report 2023. (Just out)

Sadly I have to agree with the statement of "a worthless article" for the prupose of trying to pump the stock. The article is just an overview of the sector and not specific to any company's progress, other then a mention. I believe everybody here really knows what will move this stock price. Until that happens it just a back and forth conversation.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season